UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials Journal article
Zheng,Wei, Zhu,Xiao Min, Zhang,Qing E., Cai,Dong Bin, Yang,Xin Hu, Zhou,Yan Ling, Ungvari,Gabor S., Ng,Chee H., He,Shu Hua, Peng,Xiao Jiang, Ning,Yu Ping, Xiang,Yu Tao. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials[J]. Schizophrenia Research, 2019, 209, 12-21.
Authors:  Zheng,Wei;  Zhu,Xiao Min;  Zhang,Qing E.;  Cai,Dong Bin;  Yang,Xin Hu; et al.
Favorite | TC[WOS]:18 TC[Scopus]:22  IF:3.6/4.0 | Submit date:2021/03/02
Nmda Receptor Antagonists  Schizophrenia  Memantine  Bipolar Disorder  Major Depressive Disorder  
A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor Journal article
Hu, Shengquan, Hu, Huihui, Mak, Shinghung, Cui, Guozhen, Lee, Mingyuen, Shan, Luchen, Wang, Yuqiang, Lin, Huangquan, Zhang, Zaijun, Han, Yifan. A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor[J]. FRONTIERS IN PHARMACOLOGY, 2018, 9.
Authors:  Hu, Shengquan;  Hu, Huihui;  Mak, Shinghung;  Cui, Guozhen;  Lee, Mingyuen; et al.
Favorite | TC[WOS]:17 TC[Scopus]:19  IF:4.4/5.0 | Submit date:2018/10/30
Alzheimer's Disease  Tetramethylpyrazine Derivative  Nmda Receptor  Neuroprotection  Oxidative Stress  Gsk3 Beta  
Adjunctive memantine for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials Journal article
Zheng W., Li X.-H., Yang X.-H., Cai D.-B., Ungvari G.S., Ng C.H., Wang S.-B., Wang Y.-Y., Ning Y.-P., Xiang Y.-T.. Adjunctive memantine for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials[J]. Psychological Medicine, 2018, 48(1), 72-81.
Authors:  Zheng W.;  Li X.-H.;  Yang X.-H.;  Cai D.-B.;  Ungvari G.S.; et al.
Favorite | TC[WOS]:27 TC[Scopus]:36 | Submit date:2018/12/18
Memantine  Meta-analysis  Negative Symptoms  Nmda Receptor Antagonists  Schizophrenia  
Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage Journal article
Sun C., Meng Q., Zhang L., Wang H., Quirion R., Zheng W.. Glutamate attenuates IGF-1 receptor tyrosine phosphorylation in mouse brain: Possible significance in ischemic brain damage[J]. Neuroscience Research, 2012, 74(3-4), 290-297.
Authors:  Sun C.;  Meng Q.;  Zhang L.;  Wang H.;  Quirion R.; et al.
Favorite | TC[WOS]:17 TC[Scopus]:17 | Submit date:2018/12/21
Brain Ischemia  Glutamate  Igf-1  Nmda Receptor  Tyrosine Phosphorylation  
Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons Journal article
Vaisanen J., Linden A.-M., Lakso M., Wong G., Heinemann U., Castren E.. Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons[J]. Neuropsychopharmacology, 1999, 21(1), 137-146.
Authors:  Vaisanen J.;  Linden A.-M.;  Lakso M.;  Wong G.;  Heinemann U.; et al.
Favorite | TC[WOS]:24 TC[Scopus]:25 | Submit date:2018/12/18
Hippocampus  Ketamine  Limbic Cortex  Nmda Receptor Antagonists  Phencyclidine  Posterior Cingulate Cortex  Schizophrenia  
NMDA receptor 2C subunit is selectively decreased by MK-801 in the entorhinal cortex Journal article
Linden A.-M., Vasainen J., Wong G., Castren E.. NMDA receptor 2C subunit is selectively decreased by MK-801 in the entorhinal cortex[J]. European Journal of Pharmacology, 1997, 319(1).
Authors:  Linden A.-M.;  Vasainen J.;  Wong G.;  Castren E.
Favorite | TC[WOS]:14 TC[Scopus]:14 | Submit date:2018/12/18
Entorhinal Cortex  Mk-801  Nmda Receptor